Telemedicine in COVID-19
The emergence of COVID-19 pandemic has drastically modified medical practices which increased the usage of telemedicine among different medical fields. ‘Telemedicine Usage Among Urologists During the COVID-19 Pandemic: Cross-Sectional Study” was the first study to quantify the use, usability and pervading interest in telemedicine of urologists during the pandemic. A total of 620 urologists from 58 countries participated in the survey. The result showed that the usage of telemedicine among surveyed urologists during COVID-19 increased from 15.8% to 46.1%. Despite the increased interest of urologists in telemedicine, the technology itself was one of the main obstacles preventing them from utilizing it. (J Med Internet Res. 2020 Nov 5;22(11):e21875. doi: 10.2196/21875.)
Anyone interested in future collaboration in this field of research, you are welcome to contact our key investigator Dr Jeremy TEOH of the Department of Surgery, CUHK. Dr. Teoh’s research focuses on urinary biomarkers for bladder cancer, tumour heterogeneity and molecular classification of bladder cancer, transurethral en bloc resection of bladder tumour, androgen deprivation therapy for prostate cancer and advanced robotic surgery for urological cancers.